MLTX:NASDAQ, MoonLake Immunotherapeutics

MLTX stock overview

MoonLake Immunotherapeutics (MLTX:NASDAQ) closed at $11.85 on October 23, 2026, down 3.97% on the day. The stock trades 49.1% below its 52-week high of $23.29 and 26.6% above its 52-week low of $9.36. Over the past year, it gained 24.5%. MoonLake Immunotherapeutics is part of the Finance sector.

Key figures

Price
$11.85
Day change
-3.97%
Volume
1,931,208
Average volume
1,596,717
Market cap
1B+
52-week range
$9.36 – $23.29
50-day average
$13.04
200-day average
$16.59

Price action over the past year

In 252 trading sessions since October 23, 2025, MLTX closed higher on 119 days (47%). Its best day was January 9, 2026 (+28.94%) and its worst was April 1, 2026 (-11.37%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

MLTX news

About MoonLake Immunotherapeutics

Helix Acquisition Corp is a blank check company.

Similar stocks

Find more stocks like MLTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.